These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1652 related articles for article (PubMed ID: 34339728)

  • 1. Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age.
    Das BB; Kohli U; Ramachandran P; Nguyen HH; Greil G; Hussain T; Tandon A; Kane C; Avula S; Duru C; Hede S; Sharma K; Chowdhury D; Patel S; Mercer C; Chaudhuri NR; Patel B; Ang JY; Asmar B; Sanchez J; Khan D
    J Pediatr; 2021 Nov; 238():26-32.e1. PubMed ID: 34339728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents.
    Schauer J; Buddhe S; Colyer J; Sagiv E; Law Y; Mallenahalli Chikkabyrappa S; Portman MA
    J Pediatr; 2021 Nov; 238():317-320. PubMed ID: 34228985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically Suspected Myocarditis Temporally Related to COVID-19 Vaccination in Adolescents and Young Adults: Suspected Myocarditis After COVID-19 Vaccination.
    Truong DT; Dionne A; Muniz JC; McHugh KE; Portman MA; Lambert LM; Thacker D; Elias MD; Li JS; Toro-Salazar OH; Anderson BR; Atz AM; Bohun CM; Campbell MJ; Chrisant M; D'Addese L; Dummer KB; Forsha D; Frank LH; Frosch OH; Gelehrter SK; Giglia TM; Hebson C; Jain SS; Johnston P; Krishnan A; Lombardi KC; McCrindle BW; Mitchell EC; Miyata K; Mizzi T; Parker RM; Patel JK; Ronai C; Sabati AA; Schauer J; Sexson Tejtel SK; Shea JR; Shekerdemian LS; Srivastava S; Votava-Smith JK; White S; Newburger JW
    Circulation; 2022 Feb; 145(5):345-356. PubMed ID: 34865500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
    Montgomery J; Ryan M; Engler R; Hoffman D; McClenathan B; Collins L; Loran D; Hrncir D; Herring K; Platzer M; Adams N; Sanou A; Cooper LT
    JAMA Cardiol; 2021 Oct; 6(10):1202-1206. PubMed ID: 34185045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review.
    Pillay J; Gaudet L; Wingert A; Bialy L; Mackie AS; Paterson DI; Hartling L
    BMJ; 2022 Jul; 378():e069445. PubMed ID: 35830976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
    BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of myopericarditis following COVID-19 mRNA vaccination in a large integrated health system: A comparison of completeness and timeliness of two methods.
    Sharff KA; Dancoes DM; Longueil JL; Johnson ES; Lewis PF
    Pharmacoepidemiol Drug Saf; 2022 Aug; 31(8):921-925. PubMed ID: 35404496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada.
    Buchan SA; Seo CY; Johnson C; Alley S; Kwong JC; Nasreen S; Calzavara A; Lu D; Harris TM; Yu K; Wilson SE
    JAMA Netw Open; 2022 Jun; 5(6):e2218505. PubMed ID: 35749115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children.
    Dionne A; Sperotto F; Chamberlain S; Baker AL; Powell AJ; Prakash A; Castellanos DA; Saleeb SF; de Ferranti SD; Newburger JW; Friedman KG
    JAMA Cardiol; 2021 Dec; 6(12):1446-1450. PubMed ID: 34374740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptomatic Acute Myocarditis in 7 Adolescents After Pfizer-BioNTech COVID-19 Vaccination.
    Marshall M; Ferguson ID; Lewis P; Jaggi P; Gagliardo C; Collins JS; Shaughnessy R; Caron R; Fuss C; Corbin KJE; Emuren L; Faherty E; Hall EK; Di Pentima C; Oster ME; Paintsil E; Siddiqui S; Timchak DM; Guzman-Cottrill JA
    Pediatrics; 2021 Sep; 148(3):. PubMed ID: 34088762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term outcome of late gadolinium changes detected on cardiovascular magnetic resonance imaging following coronavirus disease 2019 Pfizer/BioNTech vaccine-related myocarditis in adolescents.
    Krupickova S; Voges I; Mohiaddin R; Bautista C; Li W; Herberg J; Daubeney PEF; Pennell DJ; Fraisse A
    Pediatr Radiol; 2023 May; 53(5):892-899. PubMed ID: 36622403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac MRI Findings of Myocarditis After COVID-19 mRNA Vaccination in Adolescents.
    Chelala L; Jeudy J; Hossain R; Rosenthal G; Pietris N; White CS
    AJR Am J Roentgenol; 2022 Apr; 218(4):651-657. PubMed ID: 34704459
    [No Abstract]   [Full Text] [Related]  

  • 14. Definite Acute Myocarditis After Coronavirus Disease 2019 mRNA Vaccination.
    Maeda M; Isawa T; Tada N
    Circ J; 2022 Mar; 86(4):724. PubMed ID: 34866122
    [No Abstract]   [Full Text] [Related]  

  • 15. Patients With Acute Myocarditis Following mRNA COVID-19 Vaccination.
    Kim HW; Jenista ER; Wendell DC; Azevedo CF; Campbell MJ; Darty SN; Parker MA; Kim RJ
    JAMA Cardiol; 2021 Oct; 6(10):1196-1201. PubMed ID: 34185046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of myopericarditis after mRNA COVID-19 vaccination: A meta-analysis with focus on adolescents aged 12-17 years.
    Guo BQ; Li HB; Yang LQ
    Vaccine; 2023 Jun; 41(28):4067-4080. PubMed ID: 37246067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocarditis or Pericarditis Events After BNT162b2 Vaccination in Individuals Aged 12 to 17 Years in Ontario, Canada.
    Buchan SA; Alley S; Seo CY; Johnson C; Kwong JC; Nasreen S; Thampi N; Lu D; Harris TM; Calzavara A; Wilson SE
    JAMA Pediatr; 2023 Apr; 177(4):410-418. PubMed ID: 36848096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021.
    Hause AM; Gee J; Baggs J; Abara WE; Marquez P; Thompson D; Su JR; Licata C; Rosenblum HG; Myers TR; Shimabukuro TT; Shay DK
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(31):1053-1058. PubMed ID: 34351881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myopericarditis following COVID-19 vaccination in adolescent triplets.
    Wong JW; Bock E; Kee WS; Anderson AJ; Kothari D; Tarca AJ
    Cardiol Young; 2023 Nov; 33(11):2379-2383. PubMed ID: 37154289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of Acute Myocarditis Temporally Associated with Receipt of the mRNA Coronavirus Disease 2019 (COVID-19) Vaccine in a Male Adolescent.
    Minocha PK; Better D; Singh RK; Hoque T
    J Pediatr; 2021 Nov; 238():321-323. PubMed ID: 34166671
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 83.